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Material and methods: The IC50 of the METD in the LX-2 cells
was evaluated by the MTT assay. LX-2 cells were exposed to METD
(100-200 ng/mL) with TGF- (10 ng/mL) at 24, 48 and 72 h. RNA and
proteins were extracted, RT-PCR, qPCR and WB were performed, the
relative expression of tumor growth factor beta (TGF-), collagen
1 1 (COL1-1), smooth muscle alpha actin (-SMA), inhibitor of
metalloproteinase 1 (TIMP1), metalloproteinase 2 (MMP2), SNAIL1
an EMT marker and mitofusin 2 (MNF2) of mitochondrial function.
Endogenous -actin gene and GAPDH. ANOVA analysis (p < 0.05).
Results: The METD has a concentration of 150 ng/mL man-
tain over 80% viability in LX-2 cells. The presence of METD in
cells treated with TGF- modifies fibrogenic markers, decreasing
COL1-1 and increasing -SMA RNA expression at all times, but
increase the translational expression of -SMA at 48 and 72 h. We
find TIMP1 and MMP2 RNA overexpression, and decreased TIMP1
translational expression was found at all times. It was found Snail1
and MFN2 RNA overexpression, controversially found decreased
the translation of MNF2 at all times.
Conclusions: The METD modulates the expression of pro-
fibrogenic markers, ECM modulators and some pathways related to
EMT and mitochondrial morphology and function, attenuating the
expression of profibrogen markers in human LX-2 stellar cells. This
work was partially subsidized by PAICYT SA669-18. Registration
number of the ethics committee HI11-003.
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Background and aim: Spontaneous bacterial peritonitis (SBP)
is one of the main complications of cirrhotic patients with ascites
and is of great importance due to the high mortality rate and even
in asymptomatic patients, a high prevalence of SBP has been doc-
umented. The objective of the present study was: To calculate the
prevalence of SBP in decompensated cirrhotic patients who were
hospitalized in the HCM, as well as to identify which is the main
agent that appears in the SBP.
Material and methods: A retrospective study was performed in
cirrhotic patients with SBP who were hospitalized in the Gastroen-
terology Section of the Central Military Hospital from the period of
January 2017 to January 2018. Patients with CH with data on SBP
were included, those patients with HCC were excluded, secondary
or cirrhotic peritonitis with tumor-caused peritoneal carcinomato-
sis.
Results: A review of the records was carried out and there were
134 patients, 68 (50.7%) male, with an average age of 56.42 ± 15.27
years, the etiology of cirrhosis had alcoholic cirrhosis with 80 (40%),
autoimmune etiology 72 (36%) patients, CBP 12 (6%), cirrhosis due
to NASH 12 (6%), cirrhosis due to HBV 16 (8%) and cirrhosis due to
HCV 8 (4%). According to the reports of the cultures and antibi-
ograms, there was a higher frequency of E. Coli 84 (42%) and a
lower frequency of S. aureus 15 (8%) (See Table 1). AKI type SHR
was diagnosed in 188 (94%) of patients.
Conclusions: The most common etiology found was E. Coli ESBL
with sensitivity to carbapenems (Meropenem), so in our hospital,
the use of this type of antibiotics should be considered as first-line
treatment to avoid progression to RHS and thus decrease the day
of hospital stay and recurrence of hospitalization for SBP
Conflicts of interest: The authors have no conflicts of interest
to declare.
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Background and aim: Minimal hepatic encephalopathy (MHE)
is characterized by time of reaction, executive function, as well as
high disability and mortality. There is an absence of a Gold Standard
for its prognosis; the application of psychometric tests combined
with neurophysiological tests to identify the presence of MHE is
worldwide accepted. Critical flicker frequency (CFF)test is com-
monly used; however, there exist discrepancies with respect to the
determination of the cutoff value.
Material and methods: While analyzing CFF’s continuous scale,
the application of Logistic Regression Analysis proved to be suitable
to define the appropriate cutoff point. A set of 59 patients with
hepatic cirrhosis were studied. The ROC curve showed ambigu-
ities in the determination of the cutoff point when using “Youden’s
index” as well as the closest point on the graph to the upper left
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corner point. It was decided to apply Regression Analysis, Algebra,
Analytic Geometry and Differential Calculus to determine the cutoff
point. MINITAB software was used for computations.
Results: Regression allowed two different ways to reach the
same conclusion: CFF’s cutoff point is 38.0 Hz to identify patients
with MHE. CFF test is a promising tool but to be of help, it needs a
valid cutoff point in the scale.
Financing: Project supported by the SS / IMSS / ISSSTE-
CONACYT Sector Research Fund on Health and Social Security.
1-2017. 289979.
Project supported by the Budgetary Program E015 Research and
Technological Development in Health of the ISSSTE.
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Background and aim: SARSCov-2 infection, currently responsi-
ble virus for the pandemic, can have a multi-organic impact, recent
studies show that liver injury could be a manifestation of the dis-
ease, and liver disease could also be related to a worst prognosis.
AIM: To compare the characteristics of patients with severe COVID-
19 due to SARSCov-2 disease requiring intubation versus stable
patients.
Methods. Type of study: Observational, a case-control, nested
in a cohort study. Procedure: Complete medical records of patients
admitted for COVID-19 at a third level center were reviewed. Clin-
ical and biochemical data were collected and then characteristics
between seriously ill patients who required intubation were com-
pared versus stable patients without mechanical ventilation.
Results: We included 166 patients with COVID-19 due to
SARSCov-2 infection, 114(68.7%) were men, mean age was
50.6 ± 13.3 years old, 27(16.3%) were assessed as seriously ill
patients requiring intubation for SARS. The comparative analy-
sis between those who required intubation versus those who
remained without requiring intubation showed significant eleva-
tion of ALT, AST, LDH and D-dimer, also older age, see Table.
Conclusions: This is the first study in a Mexican cohort, which
demonstrate that
seriously ill patients have significant raises of liver enzymes
(AST, ALT) with prognostic implications in the SARSCov-2 disease
course.
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Male gender, n(%) 20 (74.1) 94 (67.6) 0.51
Albumin, g/dL 3.27 ± 0.52 3.48 ± 0.50 0.09
ALT, UI/L 225.4 ± 341.2 41.3 ± 41.1 0.003*
AST, UI/L 325.3 ± 382.4 52.8 ± 47.1 0.001*
Alkaline Phosphatase, UI/L 109.1 ± 74.8 96.8 ± 54.4 0.39
GGT, UI/L 205.6 ± 360.4 125.4 ± 163.3 0.35
Age, years-old 58.6 ± 12.7 49.1 ± 12.8 0.001*
Glucose, mg/dL 168.2 ± 95.0 149.8 ± 97.8 0.54
Urea, mg/dL 54.7 ± 37.0 42.1 ± 37.7 0.14
Creatinine, mg/dL 1.1 ± 0.7 0.9 ± 0.7 0.29
Cholesterol, mg/dL 102.9 ± 33.8 123.0 ± 27.0 0.03
Triglycerids, mg/dL 142.4 ± 45.8 145.7 ± 49.4 0.83
Direct Bilirubin, mg/dL 0.8 ± 1.7 0.3 ± 0.3 0.23
Indirect Bilirubin, mg/dL 0.8 ± 1.1 0.5 ± 0.3 0.31
Total proteins, g/dL 6.5 ± 0.7 6.3 ± 1.0 0.60
LDH, UI/L 764.6 ± 401.9 461.0 ± 185.6 0.001*
Sodium, mEq/L 128.8 ± ± 26.8 135.8 ± 3.5 0.38
Potasium, mEq/L 4.2 ± 0.4 4.0 ± 0.5 0.19
Chlorine, mEq/L 102.2 ± 5.04 100.6 ± 4.35 0.25
Calcium, mg/dL 7.8 ± 0.47 8.0 ± 0.44 0.77
Phosphorus, mg/dL 3.2 ± 1.0 3.1 ± 0.8 0.75
Magnesium, mg/dL 2.3 ± 0.3 2.2 ± 0.4 0.27
Leukocytes, cel/mm3 10.3 ± 5.1 8.7 ± 4.5 0.23
Neutrophils, cel/mm3 8.9 ± 4.6 7.1 ± 4.2 0.09
Limphocytes, cel/mm3 1.0 ± 0.4 1.0 ± 0.6 0.99
Hemoglobin, g/dL 14.7 ± 1.7 14.5 ± 2.3 0.82
Red cells Wide Distribution 14.8 ± 1.4 14.2 ± 1.4 0.15
Platelets, cel/mcL 219.7 ± 73.1 226.4 ± 86.2 0.77
Mean Platelet Volume, fL 8.9 ± 0.9 8.4 ± 0.9 0.11
Fibrinógeno, mg/dL 640.7 ± 207.5 608.6 ± 168.9 0.54
D Dimer, ng/mL 7765 ± 9109 1871 ± 4146 0.003*
Reactive C Protein, mg/L 210.3 ± 157.4 142.7 ± 121.2 0.17
Ferritin, ng/mL 782 ± 518 786 ± 1011 0.98
CPK, UI/L 169 ± 188 300 ± 462 0.36
CPK-MB, ng/dL 34 ± 42 25 ± 17 0.29
Troponine I, ng/L 49.4 ± 136.7 26.1 ± 96.3 0.45
Mioglobin, ng/mL 151 ± 151 110 ± 192 0.47
Brain Natriuretic Peptid, pg/mL 56.9 ± 80.5 136.1 ± 342.2 0.49
